Join now & save up to 80% on medication

JOIN NOW
Select Language:

Join now and save 80% on medication

Register/Login

Wegovy vs Saxenda: A Comparison

Share Post:

Wegovy vs Saxenda. Wegovy and Saxenda are both popular medications for weight loss management in overweight or obese adults. They belong to the same class of drugs called GLP-1 receptor agonists, but differ in their active ingredients and approved uses. Both semaglutide and liraglutide are synthetic versions of the hormone GLP-1, which works by regulating blood sugar levels and appetite. They also reduce hunger and increase feelings of fullness, leading to reduced calorie intake.

In addition to weight management indication, Saxenda is also FDA-approved for type 2 diabetes treatment. It reduces the risk of major adverse cardiovascular events in adults diagnosed with type 2 diabetes.

Efficacy

Clinical studies have shown that both Wegovy and Saxenda are effective in promoting weight loss. However, Wegovy has demonstrated slightly greater weight loss efficacy in some trials compared to Saxenda. In one trial, Wegovy resulted in an average weight loss of 15% of body weight. On the other hand, Saxenda only recorded weight loss of 8% of body weight.

Dosage and Administration

The following includes the proper dosage and administration of both Wegovy and Saxenda.

Wegovy is administered as a once-weekly subcutaneous injection. The dosage increases every four weeks until you reach a total dose of 2.4 mg once weekly. 

It comes in five strengths, such as:

  • 0.25 mg
  • 0.5 mg
  • 1 mg
  • 1.7 mg
  • 2.4 mg

Saxenda is administered as a once-daily subcutaneous injection. Its doses also slowly increase until you reach the daily dosage of 3 mg. It is available in different dosage strengths, including:

  • 0.6 mg
  • 1.2 mg
  • 1.8 mg
  • 2.4 mg
  • 3 mg


Cost Difference

Wegovy is more expensive than Saxenda, with an average cost of $1,349.02 for its complete package, while Saxenda costs $545.44 for one pack with five pre-filled syringes x 3ml each – 6 mg/ml.

Side Effects

Both Wegovy and Saxenda can cause similar side effects. These are as follows:

  • Nausea
  • Vomiting
  • Diarrhea
  • Constipation
  • Abdominal pain
  • Decreased appetite

There is also a potential risk of severe side effects like pancreatitis and gallbladder disease, although the overall risk is relatively low.

Which is better?

Choosing between Wegovy and Saxenda depends on several factors, including your weight, age, medical history, other medications you are taking, and potential drug interactions. Consult with a healthcare professional to determine which medication is best suited for your specific needs and condition.

In conclusion, both Wegovy and Saxenda are effective medications for weight loss management. While Wegovy may offer slightly greater weight loss efficacy, Saxenda is more affordable. Ultimately, the choice between the two medications should be made with the guidance of a healthcare professional.

Doctor’s Recommendation

Before using Saxenda or Wegovy, talk to your doctor if you have ever had an allergic reaction to either medication, are pregnant or planning to become pregnant, are breastfeeding or thinking about breastfeeding, or have a history of pancreatitis (inflammation of the pancreas). It’s also important to consult your doctor if you have type 2 diabetes, have experienced diabetic retinopathy (vision problems caused by diabetes), have kidney issues, have liver issues (for Saxenda), or have a history of depression or suicidal thoughts.

Medically Reviewed

Profile image of Lalaine Cheng

Medically Reviewed By Lalaine ChengA dedicated medical practitioner with a Master’s degree in Public Health, specializing in epidemiology with a profound focus on overall wellness and health, brings a unique blend of clinical expertise and research acumen to the forefront of healthcare. As a researcher deeply involved in clinical trials, I ensure that every new medication or product satisfies the highest safety standards, giving you peace of mind, individuals and healthcare providers alike. Currently pursuing a Ph.D. in Biology, my commitment to advancing medical science and improving patient outcomes is unwavering.

Profile image of CDI Staff Writer

Written by CDI Staff WriterOur internal team are experts in many subjects. on June 23, 2023

Related Articles

Cardiovascular Health, Diabetes,
New Data Proving Metformin is Healthy for the Heart in People with Type 2 Diabetes

Type 2 diabetes mellitus (T2DM) affects millions of people worldwide and significantly increases the risk of heart disease. While managing blood sugar levels is crucial, recent research suggests that some…

Read More
Diabetes, Diabetes Supplies,
Pioglitazone: A Promising Ally Against Sepsis in Type 2 Diabetes Patients

Understanding Sepsis and Its Impact on Diabetic PatientsSepsis is a life-threatening condition that arises when the body’s response to infection causes injury to its own tissues and organs. It’s a…

Read More
Diabetes, Diabetes Supplies,
Understanding Mechanistically How Pioglitazone Can Help Combat Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) is a growing health concern worldwide, affecting approximately 25% of the global population. Closely linked to obesity and insulin resistance, NAFLD can progress to more…

Read More
Cancer, Diabetes, Diabetes
How an Old Diabetes Drug – Pioglitazone Shows Promise in Fighting Leukemia

Acute myeloid leukemia (AML) is an aggressive cancer of the blood and bone marrow that affects thousands of people worldwide. Traditional treatments often come with severe side effects, especially for…

Read More